| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.008 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.13 | 0.01 |